Bosmon Tablet 62.5mg

About Bosmon Tablet 62.5mg

Bosmon Tablet 62.5mg Uses

• Treats pulmonary arterial hypertension (PAH) to improve exercise capacity
• Slows clinical worsening of PAH symptoms over time
• Reduces the number of new digital ulcers in patients with systemic sclerosis

Benefits

• Widens narrowed pulmonary blood vessels by blocking endothelin receptors
• Lowers pulmonary vascular resistance and eases strain on the right side of the heart
• Helps many patients walk farther with less breathlessness during daily activities

What Experts Say

Pulmonologists and cardiologists prescribe Bosmon Tablet 62.5mg as a starting dose before stepping up to the standard 125mg maintenance dose after four weeks, provided liver enzyme tests stay within safe limits.

This gradual titration lowers the chance of sudden liver enzyme spikes, a known effect of Bosentan therapy that requires monthly blood monitoring throughout treatment. Doctors also stress strict contraception counseling for women of childbearing age, since Bosentan carries a serious risk of birth defects and pregnancy must be actively ruled out before and during treatment.

Specialists view Bosentan as a valuable oral option for pulmonary arterial hypertension because it lets many patients avoid or delay continuous intravenous therapy, which carries its own infection and catheter related risks. Physicians typically pair it with regular six minute walk tests to track whether exercise capacity is genuinely improving, adjusting the treatment plan if progress stalls.

Drug Class

• Endothelin receptor antagonist (dual ETA/ETB blocker)

Bosmon Tablet 62.5mg formula

• Bosentan

Available forms

• Tablet

How to use Bosmon Tablet 62.5mg?

• Take exactly as prescribed by a pulmonologist or cardiologist, usually starting at 62.5mg twice daily
• Dose is typically increased to 125mg twice daily after four weeks if liver tests remain normal
• Swallow the tablet whole with a glass of water, with or without food
• Get liver function tests done before starting treatment and every month during treatment
• Women of childbearing age must use two reliable contraception methods and get a monthly pregnancy test
• Do not stop the medicine suddenly without medical advice, since abrupt withdrawal can worsen symptoms

Drug Interactions

• Cyclosporine A significantly raises Bosentan levels and must not be combined
• Glibenclamide (glyburide) combined with Bosentan raises the risk of liver enzyme elevation and reduces blood sugar control
• Ketoconazole and other strong CYP3A4 inhibitors increase Bosentan blood levels
• Rifampicin and other CYP450 inducers reduce Bosentan effectiveness
• Reduces the effectiveness of hormonal contraceptives, so an additional barrier method is needed
• Can lower warfarin levels, requiring closer INR monitoring
• May reduce the effectiveness of statins like simvastatin

Risks and warnings

• Can cause serious, sometimes fatal, liver damage, so regular liver function monitoring is mandatory
• Strictly contraindicated in pregnancy since Bosentan causes serious birth defects
• Not recommended for breastfeeding mothers
• May reduce sperm count and affect male fertility with long term use
• Can cause fluid retention and worsening heart failure symptoms in some patients
• Avoid in patients with moderate to severe liver disease
• Use with caution in patients with low blood pressure or on other blood pressure lowering medicines

Bosmon Tablet 62.5mg Side Effects

• Headache
• Flushing of the face
• Swelling in the legs, ankles or feet
• Low blood pressure and dizziness on standing
• Nasal congestion or a stuffy nose
• Palpitations or a fast heartbeat
• Abnormal liver function test results
• Low red blood cell count (anemia)

Storage Conditions

• Store below 30 degrees Celsius in a cool, dry place away from direct sunlight
• Keep the tablets in their original blister pack until ready to use
• Keep out of reach of children
• Do not use after the expiry date printed on the pack